Centessa Pharmaceuticals (CNTA) Change in Account Payables (2020 - 2026)
Centessa Pharmaceuticals (CNTA) reported Change in Account Payables of $3.3 million for Q1 2026, up 255.75% year-over-year from $917212.5 in Q1 2025, and up 348.7% on a QoQ basis from -$1.3 million in Q4 2025.
Centessa Pharmaceuticals (CNTA) has 7 years of Change in Account Payables data on file, last reported at $3.3 million in Q1 2026.
- Quarterly Change in Account Payables rose 255.75% year-over-year to $3.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.4 million (up 322.55% YoY) and the FY2025 annual result came in at $50000.0, up 101.09% from the prior year.
- Change in Account Payables advanced to $3.3 million in Q1 2026 per CNTA's latest filing, from -$1.3 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $3.3 million in Q3 2025 and bottomed at -$4.2 million in Q1 2024.
- The 5-year median for Change in Account Payables is $143000.0 (2024), against an average of $138647.1.
- The widest annual swing landed in 2024, when Change in Account Payables jumped 1955.42%; it then plunged 1017.48% in 2025.
- Tracing CNTA's Change in Account Payables over 5 years: stood at $2.6 million in 2022, then sank by 77.43% to $586000.0 in 2023, then plunged by 75.6% to $143000.0 in 2024, then sank by 1017.48% to -$1.3 million in 2025, then soared by 348.7% to $3.3 million in 2026.
- Per Business Quant, the three latest CNTA Change in Account Payables figures stand at $3.3 million (Q1 2026), -$1.3 million (Q4 2025), and $3.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -3.26 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 35.60 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Centessa Pharmaceuticals | 6.12 Bn | 6.12 Bn | - | 3.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.26 Mn |
| Mar 31, 2026 | 3.26 Mn |
| Dec 31, 2025 | -1.31 Mn |
| Dec 31, 2025 | -1.31 Mn |
| Sep 30, 2025 | 3.28 Mn |
| Sep 30, 2025 | 3.28 Mn |
| Jun 30, 2025 | 177,000.00 |
| Jun 30, 2025 | 177,000.00 |
| Mar 31, 2025 | -2.10 Mn |
| Mar 31, 2025 | -2.10 Mn |
| Dec 31, 2024 | 143,000.00 |
| Dec 31, 2024 | 143,000.00 |
| Sep 30, 2024 | 1.71 Mn |
| Sep 30, 2024 | 1.71 Mn |
| Jun 30, 2024 | -2.18 Mn |
| Jun 30, 2024 | -2.18 Mn |
| Mar 31, 2024 | -4.25 Mn |
| Mar 31, 2024 | -4.25 Mn |
| Dec 31, 2023 | 586,000.00 |
| Dec 31, 2023 | 586,000.00 |
| Sep 30, 2023 | 83,000.00 |
| Sep 30, 2023 | 83,000.00 |
| Jun 30, 2023 | -1.58 Mn |
| Jun 30, 2023 | -1.58 Mn |
| Mar 31, 2023 | -1.82 Mn |
| Mar 31, 2023 | -1.82 Mn |
| Dec 31, 2022 | 2.60 Mn |
| Dec 31, 2022 | 2.60 Mn |
| Sep 30, 2022 | 3.13 Mn |
| Sep 30, 2022 | 3.13 Mn |
| Jun 30, 2022 | 1.84 Mn |
| Jun 30, 2022 | 1.84 Mn |
| Mar 31, 2022 | -1.22 Mn |
| Mar 31, 2022 | -1.22 Mn |
| Dec 31, 2021 | -1.37 Mn |
| Dec 31, 2021 | -1.37 Mn |
| Sep 30, 2021 | 3.37 Mn |
| Sep 30, 2021 | 3.37 Mn |
| Jun 30, 2021 | -4.39 Mn |
| Jun 30, 2021 | -4.39 Mn |
| Mar 31, 2021 | 6.55 Mn |
| Mar 31, 2021 | 6.55 Mn |
| Dec 31, 2020 | -7,000.00 |
| Dec 31, 2020 | -7,000.00 |
| Sep 30, 2020 | 391,000.00 |
| Sep 30, 2020 | 391,000.00 |